{
  "id": "ic-c12b",
  "version": "1",
  "drug": {
    "slug": "doacs",
    "display": "DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)"
  },
  "supplement": {
    "slug": "panax-ginseng",
    "display": "Panax ginseng (Korean red ginseng)"
  },
  "severity": "caution",
  "evidenceTier": "mechanistic",
  "mechanism": "Case reports describe INR changes and bleeding with ginseng on anticoagulants; without a warfarin-style INR window on DOACs, the practical level stays low-caution. The cited anchor is the warfarin-by-ginseng interaction RCT; on DOACs the borrowing is class-level context, not a trial of this pair.",
  "patientNotes": [
    "Mention ginseng to your prescriber.",
    "Report bruising or bleeding."
  ],
  "pmids": [
    "19913311"
  ],
  "pubmedUrls": [
    "https://pubmed.ncbi.nlm.nih.gov/19913311/"
  ],
  "guideSlugs": [
    "panax-ginseng-for-ed"
  ],
  "guideUrls": [
    "https://supplementbrief.com/panax-ginseng-for-ed/"
  ],
  "pairUrl": "https://supplementbrief.com/interactions/doacs/panax-ginseng/",
  "reviewedBy": "natallia-kalistratava",
  "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
  "lastVerified": "2026-09-25",
  "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c12b.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c12b/"
}
